Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine
Crossref DOI link: https://doi.org/10.1186/s10194-016-0717-7
Published Online: 2017-02-07
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cady, Roger K.
Munjal, Sagar
Cady, Ryan J.
Manley, Heather R.
Brand-Schieber, Elimor
License valid from 2017-02-07